Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Unknown 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 225Uterine Cervical Neoplasms 181Fallopian Tube Neoplasms 93Carcinoma, Ovarian Epithelial 85Endometrial Neoplasms 74Neoplasms 37Uterine Cervical Dysplasia 35Papillomavirus Infections 35Breast Neoplasms 26Peritoneal Neoplasms 25Vulvar Neoplasms 23Condylomata Acuminata 22Vaginal Neoplasms 18Recurrence 16Testicular Neoplasms 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Burkitt Lymphoma 12Brenner Tumor 12Primary Myelofibrosis 11Multiple Myeloma 11Lymphoma, Non-Hodgkin 11Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 11Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myeloid, Accelerated Phase 11Leukemia, Lymphocytic, Chronic, B-Cell 11Blast Crisis 11

Interventions

Papanicolaou Test 1Cytological Techniques 1Colposcopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Cervical Intraepithelial Neoplasia Grade 2/3 × Gynecologic × Clear all
NCT04484415 2022-08-12

APRICITY

Jiangsu Yahong Meditech Co., Ltd aka Asieris

Phase 3 Unknown
402 enrolled
Gynecologic

Cervical Intraepithelial Neoplasia Grade 2/3

NCT03366493 2017-12-08

The Study of Folate Receptor-Mediated Staining Solution (FRDâ„¢) In Cervical Lesion Detection

GY Highland Biotech LLC

Phase 3 Unknown
200 enrolled
Gynecologic

Cervical Intraepithelial Neoplasia Grade 2/3

Data powered by HemOnc (CC BY 4.0) Colophon âš¡